Availability and role of clinical pharmacists in ambulatory neuro-oncology.

ABSTRACT:

Background

Outpatient clinics treating neuro-oncology patients are becoming more multidisciplinary. Utilization of all team members is critical for the holistic care of these complex patients. Specifically, the role of clinical pharmacist (CP) in the ambulatory clinic remains undefined and will likely evolve as more therapeutics are developed for CNS malignancies. We queried the Society for Neuro-Oncology (SNO) membership about the availability of a CP in their ambulatory setting and, if present, the role of that CP.

Methods

In an IRB-exempt study, we surveyed the SNO community and analyzed responses to queries about CPs in the ambulatory setting.

Results

Of the 65 SNO members who responded, 52 were clinical members. Of these 52 clinicians, the majority were physician

SUBMITTER: Patel MP 

PROVIDER: S-EPMC8789268 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature